Summary
- Current Price
- As of today, GRTX price is $0.04, unchanged in the most recent trading session on
- Current Price All-Time High
- GRTX price is currently -99.79% below its historical high of $19.50 set on
- Market Cap
- GRTX current market cap is $3M, up +51.85% over the past 365 days
- PE Ratio
- GRTX current PE ratio is 0.02
- Revenue
- GRTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for GRTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Galera Therapeutics, Inc. |
| Ticker | NASDAQ: GRTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | galeratx.com |
| Employees | 3 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.04 | ||
| Price, 1D Change | 0.00% | |
| $3M | ||
| - | ||
| 0.02 | ||
| 0.43 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| $1.51 | ||
| EPS, 1Y Change | +536.05% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.51 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.04 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.33 | - | |
| -$1.24 | -$0.35 | +72.02% | |
| - | $1.51 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +51.85% | ||
| -98.46% | ||
| +51.85% | ||
| -97.30% | ||
| 0.00% | ||
| 0.00% | ||
| +536.05% | ||
| +165.87% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.04 | ||
| $0.03 | ||
| SMA 200 vs Price | -36.34% | |
| $0.04 | ||
| SMA 50 vs Price | -11.71% | |
| 0.43 | ||
| $0.00 | ||
| 46.67 | ||
| 65.84% | ||
| 117.60% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $1.51 | ||
| $0.00 | ||
| - | ||
| -$6.04M | ||
| - | ||
| $149.05M | ||
| - | ||
| -$6.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 11.00 | ||
| 11.00 | ||
| - | ||
| - | ||
| -58.61 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| - | ||
| 0.78 | ||
| 0.54 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $3.97M | ||
| $6.38M | ||
| $7.20M | ||
| $7.10M | ||
| $645.00K | ||
| $645.00K | ||
| $0.00 | ||
| $0.00 | ||
| $265.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| -$149.05M | ||
| $6.04M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$6.05M | ||
| $3.50M | ||
| $635.00K | ||
| $0.00 | ||
| -$6.05M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Piper Sandler | ||
| HC Wainwright & Co. | ||
| B of A Securities | → | |
| B of A Securities | → | |
| Citigroup |
Analyst sentiment
Institutional ownership
Screeners with GRTX
FAQ
What is the ticker symbol for Galera Therapeutics, Inc.?
The ticker symbol for Galera Therapeutics, Inc. is NASDAQ:GRTX
Does Galera Therapeutics, Inc. pay dividends?
No, Galera Therapeutics, Inc. does not pay dividends
What sector is Galera Therapeutics, Inc. in?
Galera Therapeutics, Inc. is in the Healthcare sector
What industry is Galera Therapeutics, Inc. in?
Galera Therapeutics, Inc. is in the Biotechnology industry
What country is Galera Therapeutics, Inc. based in?
Galera Therapeutics, Inc. is headquartered in United States
When did Galera Therapeutics, Inc. go public?
Galera Therapeutics, Inc. initial public offering (IPO) was on November 7, 2019
Is Galera Therapeutics, Inc. in the S&P 500?
No, Galera Therapeutics, Inc. is not included in the S&P 500 index
Is Galera Therapeutics, Inc. in the NASDAQ 100?
No, Galera Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Galera Therapeutics, Inc. in the Dow Jones?
No, Galera Therapeutics, Inc. is not included in the Dow Jones index
When was Galera Therapeutics, Inc. last earnings report?
Galera Therapeutics, Inc.'s most recent earnings report was on November 9, 2022
When does Galera Therapeutics, Inc. report earnings?
The date for Galera Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- GRTX Official Website www.galeratx.com
- GRTX Profile on Yahoo Finance finance.yahoo.com/quote/GRTX
- GRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grtx